Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why do we need new and better antidepressants?

Stuart A Montgomery1

  • 1Imperial College School of Medicine, University of London, UK. stuart@samontgomery.co.uk

International Clinical Psychopharmacology
|January 27, 2006
PubMed
Summary

This review examines antidepressant efficacy, particularly in severe depression, highlighting methodological standards for evaluating treatment effectiveness and superiority. It suggests criteria for identifying antidepressants with robust efficacy or faster response times.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression with high levels of anxiety.

International clinical psychopharmacology·2019
Same author

Chairman's introduction.

Human psychopharmacology·2018
Same author

Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.

International clinical psychopharmacology·2016
Same author

Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.

The Journal of clinical psychiatry·2016
Same author

Antidepressant or antidepressant plus placebo effect?

World psychiatry : official journal of the World Psychiatric Association (WPA)·2015
Same author

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine.

Human psychopharmacology·2014

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Research Methodology

Background:

  • The efficacy of available antidepressants varies, especially in severe depression.
  • Current research methodologies may not adequately assess efficacy in severe depressive episodes.
  • Understanding mechanisms of action is crucial for antidepressant development.

Purpose of the Study:

  • To review antidepressant mechanisms and efficacy evidence, focusing on severe depression.
  • To establish minimum methodological standards for investigating antidepressant efficacy in severe depression.
  • To suggest methods for identifying superior antidepressants or those with faster response times.

Main Methods:

  • Literature review of antidepressant mechanisms of action.
  • Critical analysis of efficacy studies in major depressive disorder.

Related Experiment Videos

  • Evaluation of methodological standards for severe depression trials.

    • Main Results:

    • Not all antidepressants demonstrate clear efficacy in severe depression.
    • Specific methodological standards are required for robust efficacy assessment.
    • Properties of potentially superior or faster-acting antidepressants are discussed.

    Conclusions:

    • Rigorous methodology is essential for validating antidepressant efficacy in severe depression.
    • Further research is needed to identify antidepressants with superior or rapid-acting profiles.
    • Understanding drug mechanisms can guide the development of more effective treatments.